150 related articles for article (PubMed ID: 8304791)
1. [The usefulness of the carbohydrate antigen CA-50 in the prognosis of transitional-cell bladder carcinomas].
Moreno Sierra J; Blanco Jímenez E; Silmi Moyano A; Ortega Heredia MD; Páramo González P; Maestro de las Casas ML; Fernández Lucas C; Ramírez Fernández JC; Luengo Alpuente S; Gómez Vegas A
Arch Esp Urol; 1993 Nov; 46(9):775-8. PubMed ID: 8304791
[TBL] [Abstract][Full Text] [Related]
2. [Usefulness of carcinoembryonic antigen in transitional cell carcinoma of the bladder].
Moreno Sierra J; Ortega MD; Blanco Jimenez E; Maestro de las Casas ML; Delgado Marti JA; Hermida Gutierrez J; Salinas Casado J; Esteban Fuertes M; Resel Estévez L
Arch Esp Urol; 1994; 47(1):39-42. PubMed ID: 8192496
[TBL] [Abstract][Full Text] [Related]
3. [Serum and tissue quantification of tissue polypeptide antigen (TPA) in transitional cell carcinoma of the bladder].
Moreno Sierra J; Maestro de las Casas ML; Ortega Heredia MD; Blanco Jimenez E; Hermida Gutiérrez J; Resel Estévez L
Arch Esp Urol; 1994 Dec; 47(10):979-84. PubMed ID: 7864679
[TBL] [Abstract][Full Text] [Related]
4. [Determination of serum SCC antigen in transitional cell carcinoma of the bladder].
Moreno Sierra J; Maestro de las Casas M; Ortega Heredia MD; Rodríguez Molina J; López Asenjo J; Blanco Jiménez E; Hermida Gutiérrez J; Esteban Fuertes M; Resel Estevez L
Actas Urol Esp; 1994 Jan; 18(1):26-8. PubMed ID: 8191942
[TBL] [Abstract][Full Text] [Related]
5. [Advances regarding tumor markers in bladder cancer].
Moreno Sierra J; Chicharro Almarza GJ; Torronteras Santiago JM; Ortega Heredia MD; Maestro de las Casas ML; Silmi Moyano A; Resel Estévez L
Actas Urol Esp; 1997 Mar; 21(3):195-205. PubMed ID: 9324884
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic markers in transitional carcinoma of the bladder].
Blasco E; Gutiérrez-Hoyos A; Garrido C; Arozena F
Arch Esp Urol; 1991; 44(1):47-52. PubMed ID: 2064423
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
8. [Study of the Thomsen-Friedenreich antigen in bladder tumors].
Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Nishikawa E; Yamada Y
Hinyokika Kiyo; 1988 Feb; 34(2):260-7. PubMed ID: 3376818
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladder.
Allard P; Fradet Y; Têtu B; Bernard P
Clin Cancer Res; 1995 Oct; 1(10):1195-202. PubMed ID: 9815912
[TBL] [Abstract][Full Text] [Related]
10. [A transitional cell carcinoma of the urinary bladder with a high level of serum CA 19-9--a case report].
Saito B; Ohmuro H; Fujieda J; Yamashiro K
Gan No Rinsho; 1990 Aug; 36(9):1063-5. PubMed ID: 2381051
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against P53 protein in patients with transitional cell carcinoma of the bladder.
Sanchez-Carbayo M; Chulia MT; Niveiro M; Aranda I; Mira A; Soria F
Anticancer Res; 1999; 19(4C):3531-7. PubMed ID: 10629648
[TBL] [Abstract][Full Text] [Related]
13. [The proliferating nuclear fraction as a prognostic factor in superficial bladder carcinomas].
Belloso L; Zugasti A; Urkia M; Arozena F; Blasco-Olaetxea E
Arch Esp Urol; 1997 Oct; 50(8):831-6. PubMed ID: 9463280
[TBL] [Abstract][Full Text] [Related]
14. Prognosis in carcinoma of the urinary bladder based upon tissue blood group abh and Thomsen-Friedenreich antigen status and karyotype of the initial tumor.
Summers JL; Coon JS; Ward RM; Falor WH; Miller AW; Weinstein RS
Cancer Res; 1983 Feb; 43(2):934-9. PubMed ID: 6848204
[TBL] [Abstract][Full Text] [Related]
15. Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer.
Margel D; Tal R; Baniel J
J Urol; 2007 Dec; 178(6):2297-300; discussion 2300-1. PubMed ID: 17936837
[TBL] [Abstract][Full Text] [Related]
16. [Biologic behavior of human chorionic gonadotropin hormone (HCGH) in transitional cell carcinomas of the bladder].
Moreno Sierra J; Gómez Ruiz JJ; Rodríguez Molina J; Blanco Jiménez E; Silmi Moyano A; Corral Rosillo J; Ortega Heredia D; Maestro de las Casas ML; Resel Estévez L
Arch Esp Urol; 1993; 46(6):469-72. PubMed ID: 7691043
[TBL] [Abstract][Full Text] [Related]
17. [A case of transitional cell carcinoma of the urinary bladder with high serum level of CEA and CA19-9].
Inai H; Shimazui T; Yamamoto T; Yamauchi A; Uchida K; Takeshima H; Akaza H
Hinyokika Kiyo; 2001 Aug; 47(8):583-6. PubMed ID: 11579601
[TBL] [Abstract][Full Text] [Related]
18. Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder.
Jones HL; Delahunt B; Bethwaite PB; Thornton A
Anticancer Res; 1997; 17(1B):685-7. PubMed ID: 9066602
[TBL] [Abstract][Full Text] [Related]
19. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
[TBL] [Abstract][Full Text] [Related]
20. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]